Biological kits
Ended Purchase Order Awarded Last action
- Contract number
- 75N91024P00170
- Awardee
-
Invivoscribe, Inc. UEI R1EVMK8MEZS9
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $17,210
Award facts
- Contract value 100% obligated
- $17,210.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92121, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $17,210 firm fixed price purchase order to Invivoscribe, Inc. for biological kits. The place of performance is in San Diego, California. No set-aside designation was used for this contract. Invivoscribe will deliver the requested biological kits to the National Cancer Institute by April 22, 2024 to support the Institute's cancer research efforts. As the sole awardee, Invivoscribe will be responsible for providing the kits in accordance with the terms and conditions of the purchase order.
Quick answers
Who was awarded contract 75N91024P00170?
75N91024P00170 was awarded to Invivoscribe, Inc. by National Cancer Institute (National Institutes of Health) on January 23, 2024.
How much is contract 75N91024P00170 worth?
The government has obligated $17,210 on 75N91024P00170.
Was contract 75N91024P00170 competed?
The extent of competition for 75N91024P00170 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award